Over a million people could be offered Wegovy to cut heart attack and stroke risk on the NHS

A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive the treatment to help prevent heart attacks and strokes over the next few years. People with heart and circulatory disease who are […]

Read More  on the NHS website.